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The fluorescent amino acid, L-l-pyrenylalanine (Pya) was incorporated into [D-Ala2,Leus]enkephalin and 
its methyi ester at position 4 or 5. Pya-enkephalins howed strong fluorescent intensity and displayed high 
binding affinity for opiate receptors. Pya4-enkephalins howed high specificity for the 1 receptors, while 
Pya5-enkephalins showed high specificity and selectivity for the 6 receptors. Particularly, [D-AlaZ,PyaS]enke- 
phalin was as potent as the most utilized &specific ligand of [D-AlaZ,D-Leuqenkephalin (DADLE), and 
yet its &selectivity was about 5-times greater than that of DADLE. Thus, Pya-enkephalins per se can be 
utilized as a fluorescent probe or tracer for the opiate receptor-binding assays. 
Fluorescent enkephalin Peptide synthesis Update receptor Receptor acuity Receptor .~ele~tiv~ty 
1. INTRODUCTION 
Fluorescent derivatives of biologically active 
peptides represent useful experimental tools for the 
visualization and exploration of ligand-receptor in- 
teractions. The fluorescent groupings are usually 
introduced into peptides by covalent bonding 
through the amino, carboxyl or thiol group in their 
sequence. However, such functional groups often 
play an important role in biological action, and 
thus it is necessary to incorporate a fluorescent 
group without changing or destroying conforma- 
Abbreviations: Abbreviations used are according to 
IUPAC-IUB Commissions (1984) Eur. .I. Biochem. 138, 
P-37. Other abbreviations: DADLE, [2-D-alanine,D- 
leucinelenkephalin; DAGO, [2-D-alanine, 4-N-methyl- 
phenylalanine,5glycinol]enkephalin; DCC, dicyclo- 
hexylcarbodiimide; HOBt, I-hydroxybenzotriazole; 
Pya, L-I-pyrenylalanine; Pya4-Enk-OH and -OMe, 
[2-D-alanine,4-pyrenyIalanine,5-leucine]enkephalin and 
its methyl ester; PyaS-Enk-OH and -OMe, 1%D-alanine, 
5-pyrenyl-alaninelenkephalin and its methyl ester; Pya4- 
and Pya’-enkephalins denote analogs of enkephalins 
containing Pya at position 4 and 5, respectively 
tional and biological characteristics of the parent 
peptide. If the fluorescent core can be incor- 
porated into an amino acid as a constructive 
grouping, the usefulness of such an amino acid 
would become considerable when introduced into 
a biologically active peptide. We have developed a 
facile procedure to synthesize an optically pure 
fluorescent amino acid of L- 1 -pyrenylalanine 
(Pya) [ 11, which possesses considerably high quan- 
tum yield, long lifetime, high aromaticity, and 
high lipophilicity. Tryptophan is well-known as a 
fluorescent amino acid, but its quantum yield is 
not quite as high as compared with Pya. Here, we 
report the incorporation of Pya into the opiate 
peptide enkephalin. 
Since the discovery of the multiplicity of the 
opiate receptors, which include at least 2 distinct 
sites of &enkephalin and p-morphine receptors 
[2,3], the biological evaluation of synthesized 
enkephalin analogs has been performed by 2 dif- 
ferent pharmacological experimental procedures: 
(i) receptor-binding assays using rat brain mem- 
brane preparations, and (ii) in vitro biological 
assays using isolated and electrically stimulated 
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smooth muscle preparations. Binding assays, 
however, invariably require expensive radiolabelled 
enkephalin peptide or opiate derivatives and ex- 
perimental restrictions because of their radioactivi- 
ty. If the fluorescent enkephalin derivative posses- 
ses high receptor-binding affinity together with 
high fluorescence characteristics, it can be utilized 
much more easily as a fluorescent tracer for the 
binding assays. Thus, we have synthesized [D- 
Ala2,Pya4,Leu5]- and [D-Ala2,Pya5]enkephalins 
and their methyl ester derivatives (fig.l), and ex- 
amined the binding characteristics for the 6 and p 
receptors. Pya4-enkephaIins howed high specifici- 
ty for the g receptors, while Pyas-enkephalins 
showed high specificity and selectivity for the 6 
receptors. 
2. EXPERIMENTAL 
2.1. Syntheses of enkephalin analogs containing 
Pya 
Pya was synthesized by the asymmetric hydro- 
genation of cyclic dehydrodipeptide [4] derived 
from cyclo(-Gly-Ala-) and 1 -pyrenecarboxyalde- 
hyde; m.p. 22O’C (dec); [&? -36” (c 0.2, 
AcOH). 
Synthesis of [D-Ala2,Pya4,Leu5]enkephalin (1) 
is described briefly as a representative xample. 
Boc-Pya-OH was coupled to H-Leu-OMe by the 
DCC-HOBt method, and after removing the Boc 
group by HCl/dioxane, the dipeptide was coupled 
CH, 
I 
i 
OH (11 
H-Tyr-D-Ala-Gly-NH-CH-CO-Leu- 
OCH3 (1') 
kH* 
I OH (2) 
H-Tyr-D-Ala-Gly-Phe-NH-CH-CO- 
OCH3 (2') 
Fig.1. Chemical structures of Pya4- and Pya'-enke- 
phalins. 
with Boc-Tyr-D-Ala-Gly-OH also by DCC-HOBt. 
Saponification (1 M NaOH) of the resulting Boc- 
pentapeptide methyl ester followed by treatment 
with trifluoroacetic acid to remove the Boc group 
afforded the desired Pyaf-enkephalin (Pya4-Enk- 
OH), while Pya4-enkephali~ methyl ester (Pya4- 
Enk-OMe) was obtained by treatment with tri- 
fluoroacetic acid without saponification. Purifica- 
tions were performed by gel filtration with a 
Sephadex G-15 column in 30% AcOH. Their puri- 
ty was confirmed by silica gel thin-layer chromato- 
graphy using the following solvent systems: R!, n- 
BuOH/AcGH/pyridine/HzO (4 : 1: 1: 2); Rz, 
~HCl~/MeOH/AcOH (25 : 5 : 1). Pya4-Enk-OH, 
R! 0.78, R? 0.55; Pya4-Enk-OMe, R: 0.82, R? 0.58. 
Pya’-enkephalins were prepared similarly. The 
syntheses will be reported in detail elsewhere. 
2.2. JYuorescence characterization 
The fluorescence spectra were recorded on a 
Hitachi 650-10s spectrofluorophotometer. The 
spectra were recorded in 50 mM Tris-HCl buffer 
(pH 7.4) at 25°C with various concentrations. 
Fluorescence spectra of Pya-enkepahlins (1 x lo-’ 
M) excited at 342 nm are shown in fig.2. 
2.3. Receptor-binding assays 
Receptor-binding assays using rat brain mem- 
brane preparations were carried out essentially as 
described [S]. [3H]DADLE (40 Ci/mmol, New 
England Nuclear) and 13H]DAG0 (38 Ci/mmol, 
New England Nuclear) were used as tracers specific 
for 6 and ,U receptors, respectively, at a final con- 
centration of 0.25 nM. Incubations were carried 
out for 60 min at 25°C in 50 mM Tris-HCI buffer 
(pH 7.4) containing bestatin (1 FM) and bacitracin 
(100 pg/ml) as enzyme inhibitors. 
Dose-response curves were constructed utilizing 
1 I dose levels in duplicate. Results were analyzed 
by computer program [6] and the data used to con- 
struct the least-squares estimates of the logistic 
curves relating the binding of labelled ligand to 
concentrations of unlabelled ligand. The results 
are shown in table 1. 
3. RESULTS AND DISCUSSION 
The pyrenyl group has several interesting photo- 
hysical properties such as a long lifetime of 
yrene monomers and efficient formation of ex- 
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timers associated with its high quantum yield [7,8]. 
The fluorescence spectra of Pya4- and Pya’- 
enkephalins measured in 50 mM Tris-HCl buffer 
(pH 7.4) are shown in fig.2. All the Pya-enke- 
phalins exhibited the maximum intensity of fluor- 
escence by exciting at 342 nm, which is one of the 
absorption maxima of the Pya residue per se. It is 
of note that fluorescence mission in Tris-HCl buf- 
fer, the same buffer employed in the binding assay, 
can be detected even below 10m9 M for all Pya- 
enkephalins. These results certainly demonstrate 
that Pya-enkephalins possess sufficient fluores- 
cence properties even for utilizing them as a 
fluorescence probe in biological assay systems. 
Receptor-binding affinities of Pya-enkephalins 
were evaluated for their ability to displace [3H] 
DADLE and [3H]DAG0 for the S and ,U receptors 
in rat brain membrane, respectively (table 1). It is 
clear that all Pya-enkephalins possess considerably 
high binding potencies for both the S and ,U recep- 
tors. Pya4-enkephalins (1 and 1’) displayed almost 
the same affinity (16.3 and 11.9 nM, respectively) 
for the p receptors as DADLE (20.1 nM), while 
Pya5-enkephalins (2 and 2’) displayed almost the 
same affinity (2.2 and 3.6 nM, respectively) for the 
6 receptors as DADLE (2.14 nM). DADLE is the 
most utilized S-specific ligand to date. It should be 
noted that Pya’-enkephalins become quite S recep- 
tor selective due to the considerably diminished af- 
finity for the p receptors (113-124 nM). When the 
ability of enkephalins to discriminate between 6 
and p receptors is expressed as a ratio of the 1% 
using [3H]DAG0 vs ICSO using [3H]DADLE, both 
Pya’-enkephalins (2 and 2’) showed high S-selec- 
tivity ratios of 51 and 34, respectively, which are 
much higher than that of DADLE (9.4) (table 1). 
Fig.2. Fluorescence spectra of Pya-enkephalins in 50 
mM Tris-HCl buffer (pH 7.4) at 1 x 10m7 M. (A) 
Pya4-enkephalins, (B) Pya’-enkephalins, (-) car- 
boxylic acid, (---) methyl esters. 
These results indicate that the Pya’ residue may 
have very strong interaction with the correspon- 
ding subsites in the S receptors or its environment, 
but not with the cc receptors. 
Furthermore, this possible interaction should be 
emphasized due to the absence of a difference in 
affinity between Pya’-Enk-OH (2) and -0Me (2’) 
for both the S and y receptors. The C-terminal car- 
boxy1 group is one of the important enkephalin- 
like characteristics which result in greater specifici- 
ty and selectivity for the 6 receptors [9]. Thus, 
Pya’-Enk-OH (2) was strongly S-selective. When 
the carboxyl group is esterified or amidated, the 
derivative usually increases its affinity greatly for 
the p receptors, and becomes a non-selective 
ligand. However, Pya5-Enk-OMe (2’) displayed 
almost unchanged p-affinity and thus sustains a 
very high S-selectivity as mentioned above. This 
Table 1 
1 
Receptor binding affinity and d-selectivity of Pya-enkephalins 
Enkephalin ICSO (nM) S-selectivitya 
[‘HIDADLE [‘HIDAGO 
DADLE 2.14 20.1 9.4 
DAGO 80.2 1.45 0.018 
Pya4-Enk-OH (1) 11.8 16.3 1.4 
Pya4-Enk-OMe (1’) 73.9 11.9 0.16 
Pya5-Enk-OH (2) 2.2 113.2 51 
Pya’-Enk-OMe (2’) 3.6 123.7 34 
a Calculated from IGO &)/IC~O (6) 
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may indicate that the Pya’ residue has a very 
favorable interaction with 6 receptors and un- 
favorable interaction with the,u receptors. FauchCre 
[lo] has reported the synthesis and 6 and ,u activi- 
ties of enkephalin analogs containing so-called fat 
amino acids in position 5 such as adamantylalanine 
and tert-butylglycine. These amino acid residues 
have considerably high hydrophobicity and steric 
bulkiness. However, those amidated enkephalins 
were non-selective, exhibiting a fair potency for 
both the 6 and p receptors. High aromaticity 
and/or high lipophilicity of the pyrene ring in 
Pya’-enkephalins may be responsible for the 
discriminative recognition of 6 receptors. 
Pya4-Enk-OH (1) is non-selective, exhibiting fair 
affinities for the 6 and p receptors. When com- 
pound 1 was esterified, the resulting methyl ester 
1' displayed an almost 6-fold decrease in b-affinity 
and a slight increase in p-affinity and thus become 
p-selective. This suggests that the Pya4 residue 
possesses a reversed effect of the Pya’ residue in 
Pya’-enkephalins for the opiate receptors. These 
results, however, are comparable to the fact that 
the enkephalin amides containing fat amino acids, 
adamantylalanine or carboranylalanine in position 
4, were p receptor selective [lo]. 
Some fluorescent enkephalins have been reported 
by other groups as probes for conformational 
studies [11,12] or studies of ligand-receptor in- 
teractions [13]. These include [Trp4]enkephalins 
[ 111 and dansylated enkephalin analogs [ 12,131. 
However, their fluorescence intensity was moderate 
compared to the strong intensity of Pya-enke- 
phalins. In addition, very high receptor specificity 
and selectivity have been found for Pya-enke- 
phalins in the present study. Thus, Pya-enkephalins 
may represent a useful fluorescence probe or tracer 
to explore discriminatively the 6 and p receptors. 
Their applications to binding assays and studies on 
interactions with lipids are under our consideration. 
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